The tumor marker associated with 60–90% of yolk sac tumors is alpha fetoprotein (α-FP), and its normalization with chemotherapy is regarded as an indication of complete clinical response to the treatment [10,19,20]. The gene discussed is AFP; the disease is neoplasm.